EUROGIN 2019

CME-Punkte

Welcome to Eurogin 2019

Program Topics

• Cervical cancer screening in immunized populations
• Self-sampling: operational experiences under HPV self-sampling in an organized cervical cancer screening program

• From cytology to HPV based screening: Operational experiences from transforming screening programs in Northern Europe: lessons learned

• Triage markers for HPV-positive women: long term performance

• The new face of cytology in HPV screening and immunization era

• Mechanisms by which HPV screening prevents invasive cancer

• How to stay innovative in cervical cancer screening programs

• Eliminating HPV-related diseases: lessons learned from immunization of other infectious diseases

• HPV vaccine efficacy against invasive cancer

• Towards 1 dose HPV vaccination: evolving perspectives

• Update on HPV vaccine safety

• Impact of HPV vaccine on cancer outcomes, how soon?

• Vaccine hesitancy

• Therapeutic vaccines in development

• Commercially available tests (screening, triage and follow-up) for clinical use

• Next generation of HPV tests

• Molecular signatures of precancerous lesions: Changing paradigm of early detection.

• Revisiting the objectives: risk markers for cervical cancers

• HPV infection and induced cancers: worldwide sentinel observatory country: impact of HPV vaccine over the last decade

• Changing minds about HPV latency

• HPV beyond the scope: other sites

• Cervical cancers in central Central and Eastern Europe and Central Asia

• Marginalised and excluded populations

• The value of HPV genotypes: not all high risk HPV genotypes are at equal risk

• HPV infection and related cancers in men: rapid changes in awareness and management

• HPV 6-11: Low risk HPV infection and disease - Anogenital versus Oral

• Microbiome analysis: are we ready for clinical use?

• Rising knowledge on adenocarcinoma in the era of HPV screening

• High grade VIN: differentiation VIN clinical, molecular, virological and therapeutic differences

• Reproductive morbidity after treatment for CIN

• Challenging clinical topics

• From anal HPV infection to anal cancer: focusing on high risk populations

• Cervical cancer in elderly women

• Communication on sexually transmitted HPV: what should the clinician and patient know?

• Community groups initiatives

CONFERENCE PASS - 4 DAYS

Registration fees include:
• Participation in scientific sessions
• Congress bag
• Program book
• All printed materials of the congress

*The student rate applies to medical students, nurses, trainees and fellows (all physicians undergoing training in a temporary position). An official letter from the institution (PDF format) originally stamped and signed by the head of the department and confirming this status, must be submitted to the registration office.

**Developing countries: Albania, Algeria, Azerbaijan, Bahamas, Barbados, Belarus, Belize, Bosnia-Herzegovina, Botswana, Bulgaria, Chile, Colombia, Costa Rica, Ecuador, Egypt, Gabon, Georgia, Grenada, Iraq, Jordan, Kazakhstan, Kosovo, Libya, Macedonia, Malaysia, Mauritius, Mexico, Moldova, Montenegro, Morocco, Nauru, Panama, Peru, Romania, Russia, Saint Lucia, Saint Vincent and the Grenadines, Serbia, Seychelles, South Africa, Suriname, Thailand, Trinidad and Tobago, Tunesia, Turkmenistan, Ukraine, Uruguay

***Low income countries, supported: Afghanistan, Angola, Armenia, Bangladesh, Belize, Benin, Bhutan, Bolivia, Burkina Faso, Burundi, Cambodia, Cameroon, Cape Verde, Central African Republic, Chad, Comores, Congo Brazzaville, Congo Kinshasa, Côte d'Ivoire, Dominican Republic, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Fiji, Gambia, Ghana, Guatemala, Guinea, Guinea Bissau, Guyana, Haiti, Honduras, India, Indonesia, Jamaica, Kenya, Kiribati, Kyrgyz Republic, Laos, Lesotho, Liberia, Madagascar, Malawi, Maldives, Mali, Marshall Islands, Mauritania, Micronesia, Mongolia, Mozambique, Myanmar, Namibia, Nepal, Nicaragua, Niger, Nigeria, Pakistan, Papua New Guinea, Philippines, Rwanda, Samoa, Sao Tomé Principé, Senegal, Sierra Leone, Solomon Islands, Somalia, Sri Lanka, Sudan, South Sudan, Suriname, Swaziland, Tajikistan, Tanzania, Timor-Leste, Togo, Tonga, Tuvalu, Uganda, Uzbekistan, Vanuatu, Venezuela, Vietnam, Yemen, Zambia, Zimbabwe

Termine und Preise
02.12. - 05.12.2018
/ Ab 08:30 Uhr
Lisboa (Portugal)
/ Lisboa Congress Centre
Conference Pass - 4 Days Full Pass - 4 Days
Standard fee € 880,00 € 980,00
Students*, Developing countries** € 590,00 € 690,00
Delegates from Portugal *** Includes access to Workshop Lusofono and to all EUROGIN sessions (excepted comprehensive colposcopy course). € 570,00 € 670,00
04.12. - 07.12.2019
Principauté de Monaco (Monaco)
/ Grimaldi Forum Monaco
Early Bird Rate until June 30 Regular Rate Until Oct. 31 On-site Rate from Nov. 1
Standard fee € 650,00 € 790,00 € 890,00
Delegates from € 550,00 € 690,00 € 800,00
Students*, Developing countries** € 450,00 € 570,00 € 690,00
Low income countries supported*** € 400,00 € 470,00 € 600,00